Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 28-FEB-2023. These Common Stock will be under lockup for 89 days starting from 1-DEC-2022 to 28-FEB-2023.

Details:
In connection with this offering and the secondary offering by way of purchase and acceptance by the underwriters, the lender SBI Ventures Two Co., Ltd., the sellers Shizuka Akieda, Masahiro Sanjo and CYBERDYNE Co. , Ltd. , and our shareholder FUJIFILM Corporation, Sekisui Chemical Co., Ltd., Koichi Nakayama, JT Financial Services Co., Ltd., Shinsei Bank, Ltd., Mitsubishi HC Capital Co., Ltd., Koji Kuchiishi, Taiyo Holdings Co., Ltd., Japan Science and Technology Agency, Shibuya Industry Co., Ltd., Takakiyo Kawano, Iwatani Venture Capital LLC, Nobuhiko Tokunaga, and Cyfuse Employee Shareholding Association will provide the lead managing company with 2023, the 180th day after the listing (trading start) date (including the day) from the date of conclusion of the primary underwriting agreement. During the period up to May 29 (hereinafter referred to as “lockup period (1)”), without the prior written consent of the lead managing company , ( including common stock) (excluding sale by underwriters for purchase and acceptance, lending of the Company's common stock for over-allotment, etc.).

In addition, the seller, Nissay Capital No. 5 Investment Business Limited Liability Union, and the Company's shareholders, Nissay Capital No. 7 Investment Business Limited Liability Union, Mitsubishi UFJ Capital No. 4 Investment Business Limited Liability Union, Nagoya University and Tokai District University Wide Area Venture No. 1 Investment Business Limited Liability Union, SBI AI&Blockchain Investment Business Limited Liability Union, Cyfuse SKND Investment Business Limited Liability Union, DCI High-tech Manufacturing Growth Support Investment Business Limited Liability Union, Tokyo Venture Business Growth Support Investment Business Limited Liability Union, QB No. 1 Investment Business Limited Liability Partnership, DBJ Capital Investment Business Limited Liability Partnership, and Nissay Capital No. 6 Investment Business Limited Liability Partnership will provide the lead managing company with the date of listing (commencement of trading) from the date of conclusion of the principal during the period until February 28, 2023, which is the 90th day after Sale of the Company's shares without prior written consent (however, if the underwriter's secondary offering by purchase transaction and the sale price is 1.5 times or more of the issue price in "1. (excluding sales on the Tokyo Stock Exchange, etc.).